ArticlePhysiological reports2026
Selective loss of Cx40 and conduction abnormalities underlie enhanced atrial fibrillation susceptibility in a HFpEF model in male mice.
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Heart failure with preserved ejection fraction (HFpEF) is frequently complicated by atrial fibrillation (AF), yet the mechanisms underlying AF vulnerability prior to or independent of extensive structural remodeling remain incompletely understood. In this study, we investigated atrial electrophysiological remodeling in a murine HFpEF model induced by combined high-fat diet and L-NAME administration. The model reproduced key HFpEF features, including obesity, hypertension, preserved systolic function, diastolic dysfunction, and impaired exercise capacity. Transesophageal atrial pacing revealed a marked increase in AF inducibility in HFpEF mice. Ex vivo optical mapping demonstrated prolonged action potential duration, global conduction slowing, and increased conduction heterogeneity in the left atrium. Notably, atrial fibrosis, inflammation, and atrial enlargement were absent. Instead, both gene and protein expression analyses showed a selective downregulation of connexin 40 (Cx40), while connexin 43 expression was preserved. Immunohistochemistry confirmed reduced expression and altered localization of Cx40 in atrial myocardium. These findings indicate that Cx40 downregulation and gap junction dysfunction precede structural remodeling and constitute a primary electrophysiological AF substrate. Our results highlight impaired atrial conduction as a primary mechanism of AF vulnerability in this metabolic HFpEF model and provide new insights into the pathogenesis of HFpEF-associated AF that may inform future preventive strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.